These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 20536617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF.
    Ned Tijdschr Geneeskd; 2006 Sep 30; 150(39):2127-30. PubMed ID: 17059084
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Statins and stroke prevention.
    Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J.
    Cerebrovasc Dis; 2007 Sep 30; 24(2-3):170-82. PubMed ID: 17596685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW, Badellino KO.
    J Cardiovasc Nurs; 2008 Sep 30; 23(1):8-13. PubMed ID: 18158500
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Statins for prevention of stroke?].
    Strandberg T.
    Duodecim; 1999 Sep 30; 115(12):1277-8. PubMed ID: 11877827
    [No Abstract] [Full Text] [Related]

  • 13. Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.
    Uchiyama S, Nakaya N, Mizuno K, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Nakamura H, MEGA Study Group.
    J Neurol Sci; 2009 Sep 15; 284(1-2):72-6. PubMed ID: 19423132
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases.
    Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Szapary L, Feher G.
    Int J Cardiol; 2011 Apr 14; 148(2):131-8. PubMed ID: 20843571
    [Abstract] [Full Text] [Related]

  • 18. [Does statin therapy reduce the risk of stroke? A meta-analysis].
    Sirol M, Bouzamondo A, Sanchez P, Lechat P.
    Ann Med Interne (Paris); 2001 Apr 14; 152(3):188-93. PubMed ID: 11431579
    [Abstract] [Full Text] [Related]

  • 19. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W, Gmiński J.
    Przegl Lek; 2000 Apr 14; 57(5):291-5. PubMed ID: 11057120
    [Abstract] [Full Text] [Related]

  • 20. [Statins and cerebrovascular disease: new perspectives in stroke prevention].
    Castilla-Guerra L, Fernández-Moreno MC, López-Chozas JM, Jiménez-Hernández MD.
    Rev Neurol; 2000 Apr 14; 44(2):95-100. PubMed ID: 17236149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.